ASM Microbe 2017 Final Program 

ASM Microbe 2017 Exhibit and Poster Hall Activity Guide 

Claim CE Credit

Purchase Session Recordings


MEETING LOCATION

Ernest N. Morial Convention Center
900 Convention Center Blvd.
New Orleans, LA 70130
www.mccno.com

"This meeting is ESSENTIAL for researchers, educators, and students in microbiology. This is where ideas and expertise are shared and debated, and where students can meet people who are otherwise just names on papers."
Charles Wimpee, Associate Professor, University of Wisconsin

Late-breaker Submission Steps

Summary of Submission Steps

ASM Membership is not required to submit an abstract. 

Step One: Login
Step Two: New Submission 
Step Three: Affirmations
Step Four: Title
Step Five: Primary Author
Step Six: Tracks and Subtracks
Step Seven: Keywords
Step Eight: Abstract Text
Step Nine: Acknowledgements and References
Step Ten: Additional Information
Step Eleven: Review Your Work 

Step One: Login 

Please use your ASM Single Sign On (SSO) login credentials. If you forgot your username/password or need to confirm that you have a Single Sign On (SSO) account, press the "Password Reminder" link on the homepage of the submission site. If you do not have an ASM Single Sign On (SSO) account, you may create one by following the link on the homepage of the submission site.

Back to list of submission steps. 

Step Two: New Submission
Click the "New Submission" button to begin the abstract submission process.

Back to list of submission steps. 

Step Three: Affirmations

In order to proceed with the abstract submission, your agreements with the following statements are required.

ASM Membership is not required to submit an abstract.

  • All authors are aware that their names appear on this abstract.
  • If accepted for poster presentation, the presenting author agrees to place this poster on the assigned poster board for the entire time allotted for viewing and it will be removed at the time specified.
  • If accepted for oral presentation, the presenting author agrees to present the abstract during the scheduled time/date.
  • The presenting author will keep ASM informed of any changes to the contact information provided.
  • I understand that if this abstract is withdrawn after March 31, 2017, or if one of the authors does not appear to present an accepted abstract, a penalty may be incurred prohibiting the presenting author from presenting papers at ASM-sponsored meetings for a period of up to three years.
  • I understand that if this abstract is accepted, I will comply with the rule (if applicable) that all presentations dealing with the isolation, purification, structure-activity relationships, mechanisms of action, in vivo/in vitro microbiology, PK/PD in animals and Pre-US IND or non-US early phase I studies must include meaningful data (e.g., producing organism, purification steps, physical-chemical characterization, structures, MICs, ED50s) to describe new compounds and their properties and that chemical structures of lead compounds will be included as part of my poster presentation.
  • I understand that if this abstract is accepted, ASM will own the rights to any electronic or print compilation of conference abstracts, as outlined in ASM’S COPYRIGHT POLICY.

Back to list of submission steps. 

Step Four: Title

Please use a short and concise title that indicates the content of the abstract.

  • Capitalize the first letter of each word except prepositions, articles and species names.
  • Title is not included in the total character count of 2200.
  • Do not place a period at the end of your title.
  • Do not place hard returns in your title.
  • Italicize scientific names of organisms by highlighting the scientific name by selecting the italics button (example: Staphylococcus aureus will appear as “Staphylococcus aureus”). Instructions: Click here for instruction on how to italicize keyword(s) using HTML coding.
  • Trade names are not permitted in abstract titles.
  • The title submitted must be the title on your poster.
    • Examples of a properly formatted title:
      • Cryptococcus neoformans in Black, White and Color
      • Real Time PCR Assay for G. destructans Identification in Fungal Cultures and in Bat Tissues
      • In Vitro and In Vivo Characterization of Orf6, a Putative Thioesterase

Back to list of submission steps. 

Step Five: Presenting Author

Authors, groups and institutions are not included in the 2200 character limit – spaces are not counted.

Author's names will be displayed using first initial(s) and full last name. Presenting authors will be displayed in bold type (e.g. J. Smith, W.S. Brown, and R.A. Jones).

Each institution and author will be referenced with superscript numbers and include the institution’s city, two-letter state/province abbreviation and country.

Please note that ASM will correspond with the presenting author only. Changes in the presenting author must be communicated to ASM. It is the responsibility of the presenting author to contact all co-authors with the disposition and scheduling of the abstract. The complete address of the presenting author is required in order to assure that correspondence arrives promptly and easily.

Special Note: Any communication about your abstract will come from ASMMICROBEMTGPROGRAM@ASMUSA.ORG. Please add ASMMICROBEMTGPROGRAM@ASMUSA.ORG to your ‘safe senders’ list in your email program to alleviate bounce backs or your notification being sent to a junk mail folder.

CME/CE Disclosure of Relevant Financial Relationships:

In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The France Foundation adheres to requirements and policies of the ACCME. Disclosure of the planning committee, content reviewers, and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

Please note important information regarding disclosing commercial relationships below:

  • A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
  • Relationships with governmental agencies (e.g., the NIH) and organizations that do not fit the above definition do not have to be disclosed. You do not have to disclose honoraria or fees you have received from a CME provider, even if those funds were provided through an educational grant from a commercial interest.
  • Principle investigators must report research funding relationships below under "Research Contractor" even if those funds came to an institution.
  • You must disclose financial relationships your spouse or life partner has with applicable manufacturers or provides marketing advice to applicable manufacturers.

Instructions:

  • If you have nothing to disclose, please mark the box to the left of “I do not have any commercial relationships to disclose.”
  • If you have any relevant financial relationship(s) to disclose, type the company's name in the "Commercial Entity" box below and complete the additional information regarding the relationship and spouse or life partner relationships. Click on either “Save and Exit" when complete.
  • Please review your entry after you have saved your data to ensure accuracy. You may return only at this point to make changes to your disclosures.

Back to list of submission steps. 

Step Six: Tracks and Sub-tracks

For purposes of review and programming, abstracts are divided into tracks. Selection of the most appropriate track is important as it determines who reviews your abstract.

Please carefully review all sub-tracks to ensure that your abstract fits the track you select. The Review Committee reserves the right to reassign your abstract to a more appropriate track/sub-track.

Back to list of submission steps. 

Step Seven: Keywords

Keywords are completely independent of each other and should be able to stand alone in the index. Words should be lowercase, except for genus names and proper nouns. For Greek characters, please spell out names. Organisms will be italicized in final products. Enter up to three keywords.

Click the "Continue" button.

Back to list of submission steps. 

Step Eight: Abstract Text (included in the 2200 character limit – spaces are not counted)

Your abstract may have up to 2200 characters, which does not include title, authors, and affiliations. Tables and graphics (maximum of 500 characters) are included in the character count. Spaces are not counted. Do NOT include abstract title, authors or keywords in abstract text. Abstract text may be submitted using either of the following methods: Copy/paste, direct entry keystrokes, or file upload. Your abstract may be written without the use of the following bolded headers (Background, Methods, Results, Conclusion). However, follow the abstract guidelines to ensure all required information about your study is provided in your abstract.

Please note: Apple Macintosh Users Only
To preserve formatting, scientific characters, and tables embedded in your abstract text, please use the Upload a File Containing Your Abstract.

Tables:

  • Once your abstract text is saved, you will be given the opportunity to add a graphic or table.
  • The recommended table size is 5 columns by 8 rows.
  • Table Generator: Limit of 5 columns and 8 rows. Use tab to move between cells. Online instructions are available as you proceed.
  • You may also upload your table as a graphic.
  • Tables will not be adapted for publication.

Graphics:

  • The recommended graphic size, to optimize resolution, is 2 inches wide by 3 inches tall and 300 DPI.
  • The graphics count as 500 characters which are included in the 2200 character limit.
  • The graphics are submitted separately, subsequent to abstract text.
  • Graphics will appear large on the screen, but will be adapted for publication

Back to list of submission steps. 

Step Nine: Acknowledgements and References

You can use this step to:

  1. Cite referenced journal articles noted in your abstract
  2. Insert acknowledgements of financial support for the research
  3. Insert required disclaimers from government agencies about the research

Note: Acknowledgement Block below has limit of 300 characters.

Back to list of submission steps. 

Step Ten: Additional Information

ASM Event Release & License

This Release & License Form shall serve as formal consent, permission, and authorization from the undersigned (“Participant”) regarding the 2017 ASM Microbe (the “Event”) occurring on June 1-5, 2017.

Digital Recordings

  • As part of the educational mission of the American Society for Microbiology (“ASM”), arrangements have been made for recording and producing digital versions of the Event.
  • Participant hereby grants permission to ASM and its agents, including contractors, to photograph, videotape, audio record, and interview Participant, and to use his/her image, name, and likeness (which may include biographical data) in any resulting photograph(s), video(s), and/or recorded interview(s) (collectively, the “Recordings”), in whole or in part, in all forms of media including by not limited to electronic rights, marketing and promotion materials, and for-sale materials relating to the Event, ASM, and ASM's educational or membership programs.
  • Participant hereby releases, discharges and acquits ASM, its members, officers, directors, employees, affiliates, sponsors, licensees, agents, contractors, and subcontractors ("Released Parties") from any and all claims, demands, or causes of action that Participant may hereafter have against Released Parties whether for defamation, violation of privacy, or anything else resulting from the recording, duplication, distribution, or sale of the Recordings.
  • Participant understands that ASM shall retain all intellectual property rights in the Recordings or any resulting media utilizing the Recordings.
  • In the event that attendees capture and/or stream audio and video (“Capture”), ASM is not responsible for such Capture or for any subsequent use or posting of such Capture.

Use of Presentation Materials

In the event that Participant is speaking or presenting at the Event:

  • Participant hereby grants ASM a royalty-free, nonexclusive worldwide license, as of the date below, to use, modify, publish, reproduce, prepare derivative works, distribute, publicly display, and archive any and all written, electronic, video, recorded, or graphical material that Participant presents or submits in connection with the Event, including but not limited to abstracts and papers (singly and collectively the “Presentation Materials”), in whole or in part, in all forms of print and electronic media, for commercial or noncommercial use. Participant’s license to ASM also includes the right for ASM to sublicense to others any or all of the aforementioned rights regarding Presentation Materials for commercial or noncommercial use.
  • Participant represents and warrants that Participant's Presentation Materials are original to Participant or that he/she has the right to use such Presentation Materials. Should any of Participant's Presentation Materials require permission for the uses described in this Release, Participant will obtain that permission from the copyright holder of such right prior to the date of Participant's presentation(s). Participant further represents and warrants that the Presentation Materials do not contain any material that will violate the copyright or any personal, proprietary, or other right of any person or entity, and that the Participant has the full power to grant the rights he/she has granted herein.
  • Participant understands that he/she retains any ownership rights in the Presentation Materials unless Participant is a federal employee (see below). Participant further understands that ASM shall own and retain all intellectual property rights in any printed or electronic collection or compilation of Presentation Materials in whole or in part from this Participant and other Participants. Participant also understands that this Release & License form does not prohibit the Participant from using the Presentation Materials in the future in Participant’s professional or personal work.
  • Special Notice for U.S. Government Employees. ASM acknowledges that Presentation Materials authored solely by U.S. Government employees within the scope of their employment are not subject to U.S. copyright. If Participant is a U.S. Government employee, the license of rights granted herein by Participant to ASM shall not apply, but all other provisions do apply. Participants that are U.S. Government employees must check the box below.
  • Participant understands that upon request, he/she shall be entitled to a free copy of any resulting media related to the permissions granted herein.

General Provisions

  • Participant understands that ASM shall have no liability to Participant whatsoever, express or implied, for the information, ideas, concepts, or opinions related to the Recordings and/or the Presentation Materials. Participant hereby agrees to indemnify, defend, and hold harmless ASM for any claims of intellectual property infringement brought by any third party based on Participant’s use of third party materials in the Recordings and/or the Presentation Materials.
  • This Release & License form will inure to the benefit of the Released Parties, their successors, and assigns.
  • Participant understands that his/her signature below represents his/her acceptance of the foregoing terms and releases ASM from any financial or legal responsibility for the use of his/her image, name, and likeness and/or the Recordings and/or the Presentation Materials as specified herein.

Click the “Continue” button.

Back to list of submission steps. 

Step Eleven: Review Your Work

It is very important that you review you work to proof accuracy of all elements of the submitted abstract including spelling and figures. Ensure that the character count is within the 2200 character limit and that all submitted tables and graphics are completely submitted and appear in the abstract text to guarantee that the abstract submission process is complete.

Back to list of submission steps. 

Technical Support

If you have any questions regarding use of the abstract submission site please contact technical support:
Email: support@abstractsonline.com | Phone: (217) 398-1792 | Fax: (217) 355-010

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

94650